Raloxifene vs placebo
Adverse events ‐ migraine · women with endometriosis, following complete surgical excision of lesions
It is very uncertain whether raloxifene changes adverse events ‐ migraine compared with placebo (very low certainty).
1 finding from 1 review
- Selective oestrogen receptor modulators (SERMs) for endometriosis 2021 · Cochrane Headline outcomes onlyRR 0.73 [0.28, 1.95]1 study · 93 participantsVery low